A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers

NCT01436565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor Cancers

Interventions

DRUG: MM-121 (SAR256212)
DRUG: SAR245408

Sponsor

Sanofi

Collaborators

[object Object]